Abstract
Starting from vanillin, known four benzyl bromides with Br were synthesized. The first synthesis of natural product 3,4-dibromo-5-((methylsulfonyl)methyl)benzene-1,2-diol (2) and 3,4,6-tribromo-5-((methylsulfonyl)methyl)benzene-1,2-diol (3) and derivatives were carried out by demethylation, acetylatilation, oxidation and hydrolysis reactions of the benzyl bromides. Also, these compounds were tested against some important enzymes like acetylcholinesterase and butyrylcholinesterase enzymes, carbonic anhydrase I, and II isoenzymes. The novel bromophenols showed Ki values of in range of 53.75 ± 12.54-234.68 ± 46.76 nM against hCA I, 42.84 ± 9.36 and 200.54 ± 57.25 nM against hCA II, 0.84 ± 0.12-14.63 ± 3.06 nM against AChE and 0.93 ± 0.20-18.53 ± 5.06 nM against BChE. Induced fit docking process performed on the compounds inhibiting hCA I, hCA II, AChE, and BChE receptors. Hydroxyl group should exist at the aromatic ring of the compounds for inhibition of the enzymes. The moieties reported in this study will be useful for design of more potent and selective inhibitors against the enzymes.
Keywords:
Acetylcholinesterase; Bromination; Bromophenol; Carbonic anhydrase; Enzyme inhibition; Molecular docking.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylcholinesterase / chemistry
-
Acetylcholinesterase / metabolism
-
Biological Products / chemical synthesis*
-
Biological Products / metabolism
-
Biological Products / pharmacokinetics
-
Bromobenzenes / chemical synthesis*
-
Bromobenzenes / metabolism
-
Bromobenzenes / pharmacokinetics
-
Butyrylcholinesterase / chemistry
-
Butyrylcholinesterase / metabolism
-
Carbonic Anhydrase I / chemistry
-
Carbonic Anhydrase I / metabolism
-
Carbonic Anhydrase II / chemistry
-
Carbonic Anhydrase II / metabolism
-
Carbonic Anhydrase Inhibitors / chemical synthesis*
-
Carbonic Anhydrase Inhibitors / metabolism
-
Carbonic Anhydrase Inhibitors / pharmacokinetics
-
Carrier Proteins
-
Cholinergic Antagonists / chemical synthesis*
-
Cholinergic Antagonists / metabolism
-
Cholinergic Antagonists / pharmacokinetics
-
Cholinesterase Inhibitors / chemical synthesis
-
Cholinesterase Inhibitors / metabolism
-
Cholinesterase Inhibitors / pharmacokinetics
-
Humans
-
Molecular Docking Simulation
-
Nerve Tissue Proteins
-
Phenols / chemical synthesis*
-
Phenols / metabolism
-
Phenols / pharmacokinetics
-
Protein Binding
Substances
-
Acetylcholinesterase
-
Biological Products
-
Bromobenzenes
-
Butyrylcholinesterase
-
Carbonic Anhydrase I
-
Carbonic Anhydrase II
-
Carbonic Anhydrase Inhibitors
-
Cholinergic Antagonists
-
Cholinesterase Inhibitors
-
Phenols
-
BCHE protein, human
-
CA1 carbonic anhydrase, human
-
CA2 protein, human
-
Carrier Proteins
-
Nerve Tissue Proteins